InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by BEDU-ADDO FRANK. Director active across 1 company, notably PDS Biotechnology Corp. In total, 3 reports have been logged. Activity tracked since 15 June 2021. The latest transaction was filed on 2 December 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations